Results for tag: "Neurofibroma Drug"

The Neurofibroma Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurofibroma drugs are used to treat neurofibromatosis, a genetic disorder that causes tumors to grow on nerve tissue. These drugs are used to reduce the size of tumors, reduce pain, and improve the quality of life for those affected by the disorder. Commonly used drugs include vincristine, interferon, and bevacizumab. Some companies in the Neurofibroma Drug market include Pfizer, Novartis, Merck, and Roche. These companies are involved in the research, development, and production of drugs used to treat neurofibromatosis. Show Less Read more